“巢跃奇迹·希望画语系列”卵巢癌公益科普行动落地

Core Insights - The "Nest Leap Miracle: Hope Painting Series" public welfare initiative aims to enhance public awareness of ovarian cancer and support patients' survival hopes [1][2] - Ovarian cancer is often diagnosed at an advanced stage due to non-specific early symptoms, with approximately 55,000 new cases reported annually in China [2] - The five-year survival rate for ovarian cancer patients in China has improved to 39.6% from 2019 to 2021, aided by comprehensive treatment approaches and advancements in genetic testing [2][3] Group 1 - The initiative is a collaboration between Energy China Public Welfare Platform and AstraZeneca China, supported by the MiJian Patient Platform [1] - The project has entered its third year, utilizing oil painting as a creative medium to convey the hopes of patients and medical professionals [1] - The series of posters will be exhibited in various cities and online platforms starting June 9 [1] Group 2 - Ovarian cancer is referred to as a "silent killer" due to its low early diagnosis rate, with 70% of patients experiencing recurrence within two to three years after initial treatment [2] - The implementation of a comprehensive management treatment model combining surgery, chemotherapy, and maintenance therapy has contributed to the increase in survival rates [2] - The rise of genetic testing technologies like BRCA and HRD has facilitated personalized treatment, leading to longer survival for patients [2][3] Group 3 - Professor Li Li emphasizes the transition of ovarian cancer into a chronic disease management era, highlighting the importance of standardized treatment and patient support [3] - The focus on sharing success stories and professional knowledge aims to boost the determination of ovarian cancer patients in their fight against the disease [3]